Uhhh... Col you've just found a super big deal.
Professor Enzo Porrello is with, you guessed it, Novo Nordisk's stem cell arm. The foundation I mentioned that has a focus area in CHF as those tweets reiterate.
Not only is he associated with them, but he's also the Director based in Melbourne... Been there for 2 and a bit years, but all of it since MSB's phase 3 clinical data for CHF has been available.
What is a stem cell company we know that has a CHF therapy in development based in Melbourne? I hope he's doing more than just taking an interest in his own research...
I really really really want to be right.
https://renew.science/principal_investigat/enzo-porrello/
Uhhh... Col you've just found a super big deal. Professor Enzo...
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |